In Vitro Diagnostics Market Segmentation
In Vitro Diagnostics Product & Service Outlook (USD Billion, 2018-2032)
Reagents & Kits
Instruments
Data Management Software
In Vitro Diagnostics Application Outlook (USD Billion, 2018-2032)
Infectious Disease
Non-Infectious Disease
In Vitro Diagnostics Regional Outlook (USD Billion, 2018-2032)
North America Outlook (USD Billion, 2018-2032)
North America In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
North America In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
US Outlook (USD Billion, 2018-2032)
US In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
US In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
CANADA Outlook (USD Billion, 2018-2032)
CANADA In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
CANADA In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Europe Outlook (USD Billion, 2018-2032)
Europe In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Europe In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Germany Outlook (USD Billion, 2018-2032)
Germany In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Germany In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
France Outlook (USD Billion, 2018-2032)
France In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
France In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
UK Outlook (USD Billion, 2018-2032)
UK In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
UK In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
ITALY Outlook (USD Billion, 2018-2032)
ITALY In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
ITALY In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
SPAIN Outlook (USD Billion, 2018-2032)
Spain In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Spain In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Rest Of Europe Outlook (USD Billion, 2018-2032)
Rest Of Europe In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
REST OF EUROPE In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Asia-Pacific Outlook (USD Billion, 2018-2032)
Asia-Pacific In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Asia-Pacific In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
China Outlook (USD Billion, 2018-2032)
China In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
China In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Japan Outlook (USD Billion, 2018-2032)
Japan In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Japan In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
India Outlook (USD Billion, 2018-2032)
India In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
India In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Australia Outlook (USD Billion, 2018-2032)
Australia In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Australia In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
Rest of Asia-Pacific In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Rest of Asia-Pacific In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Rest of the World Outlook (USD Billion, 2018-2032)
Rest of the World In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Rest of the World In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Middle East Outlook (USD Billion, 2018-2032)
Middle East In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Middle East In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Africa Outlook (USD Billion, 2018-2032)
Africa In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Africa In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
Latin America Outlook (USD Billion, 2018-2032)
Latin America In Vitro Diagnostics by Product & service
Reagents & Kits
Instruments
Data Management Software
Latin America In Vitro Diagnostics by Application
Infectious Disease
Non-Infectious Disease
1 Report Prologue
2 Market Introduction
2.1 Scope of Study 21
2.2 Research Objective 21
2.3 List of Assumptions 21
2.4 Market Structure 22
3 Research Methodology
3.1 Research Process 24
3.2 Primary Research 25
3.3 Secondary Research 26
3.4 Market Size Estimation 27
3.5 Forecast Model 27
4 Market Dynamics
4.1 Introduction 29
4.2 Drivers 30
4.2.1 Rising prevalence of chronic and infectious diseases 30
4.2.2 Growing awareness of personalized medicine 31
4.2.3 Increasing adoption of point-of-care testing 32
4.2.4 Rising investments in research and development and collaborations between companies and
public organizations 32
4.3 Restraints 33
4.3.1 Unfavorable reimbursement scenario 33
4.3.2 Lack of standardization and transparency 33
4.3.3 Information and interest gap between investors and developers 33
4.4 Opportunities 34
4.4.1 Recent technological advancements have increased the appeal of in-vitro diagnostics 34
4.4.2 Developing economies provide an unserved market for in-vitro diagnostics 34
4.4.3 Growing significance of companion diagnostics 34
5 Market Factor Analysis
5.1 Porters Five Forces Analysis 36
5.1.1 Bargaining Power of Suppliers 36
5.1.2 Bargaining Power of Buyers 37
5.1.3 Threat of New Entrants 37
5.1.4 Threat of Substitutes 37
5.1.5 Intensity of Rivalry 37
5.2 Value Chain Analysis 38
5.2.1 Primary activities 38
5.2.2 Secondary Activities 38
6 In-Vitro Diagnostics Market, By Product & Services
6.1 Introduction 40
6.1.1 Reagents & Kits 41
6.1.2 Instruments 41
6.1.3 Data Management Software 41
7 In-Vitro Diagnostics Market, By Technology
7.1 Introduction 44
7.1.1 Immunoassay/Immunochemistry 45
7.1.2 Clinical Chemistry 47
7.1.3 Molecular Diagnostics 47
7.1.4 Microbiology 48
7.1.5 Hematology 48
8 In-Vitro Diagnostics Market, By Application
8.1 Introduction 50
8.1.1 Infectious Diseases 51
8.1.2 Non-Infectious Diseases 51
9 In-Vitro Diagnostics Market, By End User
9.1 Introduction 54
9.1.1 Hospitals 55
9.1.2 Laboratories 55
9.1.3 Academic Institutes 55
10 Global In-Vitro Diagnostics Market, By Region
10.1 Introduction 57
10.2 Americas 58
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.2.1 North America 62
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.2.1.1 US 66
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.2.1.2 Canada 69
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.2.2 South America 72
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.3 Europe 76
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4 Western Europe 80
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4.1 Germany 84
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4.2 UK 88
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4.3 France 91
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4.4 Spain 95
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4.5 Italy 98
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4.6 Rest of Western Europe 101
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.4.7 Eastern Europe 105
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.5 Asia-Pacific 109
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.5.1 China 113
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.5.2 Japan 116
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.5.3 India 119
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.5.4 Australia 122
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.5.5 Rest of Asia-Pacific 126
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.6 Middle East & Africa 130
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.6.1 Middle East 134
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
10.6.2 Africa 138
In-Vitro Diagnostics Market, By Product & Services
In-Vitro Diagnostics Market, By Technology
In-Vitro Diagnostics Market, By Application
In-Vitro Diagnostics Market, By End User
11 Competitive Landscape
11.1 Competitive Scenario 143
11.1.1 Introduction 143
11.2 Company Market Share Analysis 144
11.2.1 Introduction 144
11.3 Key Developments 145
12 Company Profile
12.1 F. Hoffmann-La Roche AG 148
12.1.1 Company Overview 148
12.1.2 Financial Overview 148
12.1.3 Products & Services Offered 149
12.1.4 Key Developments 149
12.1.5 SWOT Analysis 149
12.1.6 Key Strategy 149
12.2 Abbott Laboratories 150
12.2.1 Company Overview 150
12.2.2 Financial Overview 150
12.2.3 Products & Services Offered 151
12.2.4 Key Developments 151
12.2.5 SWOT Analysis 151
12.2.6 Key Strategy 151
12.3 Siemens AG 152
12.3.1 Company Overview 152
12.3.2 Financial Overview 152
12.3.3 Products & Services Offered 153
12.3.4 Key Developments 153
12.3.5 SWOT Analysis 153
12.3.6 Key Strategy 153
12.4 Bio-Rad Laboratories, Inc. 154
12.4.1 Company Overview 154
12.4.2 Financial Overview 154
12.4.3 Products & Services Offered 155
12.4.4 Key Developments 155
12.4.5 SWOT Analysis 155
12.4.6 Key Strategy 155
12.5 Qiagen N.V. 156
12.5.1 Company Overview 156
12.5.2 Financial Overview 156
12.5.3 Products & Services Offered 157
12.5.4 Key Developments 157
12.5.5 SWOT Analysis 157
12.5.6 Key strategy 157
12.6 BioMérieux S.A. 158
12.6.1 Company Overview 158
12.6.2 Financial Overview 158
12.6.3 Products & Services Offered 159
12.6.4 Key Developments 159
12.6.5 SWOT Analysis 159
12.6.6 Key Strategy 159
12.7 Becton, Dickinson and Company 160
12.7.1 Company Overview 160
12.7.2 Financial Overview 160
12.7.3 Products & Services Offered 161
12.7.4 Key Developments 161
12.7.5 SWOT Analysis 161
12.7.6 Key Strategy 161
12.8 DiaSorin S.p.A 162
12.8.1 Company Overview 162
12.8.2 Financial Overview 162
12.8.3 Products & Services Offered 163
12.8.4 Key Developments 163
12.8.5 SWOT Analysis 163
12.8.6 Key Strategy 163
12.9 Ortho Clinical Diagnostics (Part of Johnson & Johnson Services Inc.) 164
12.9.1 Company Overview 164
12.9.2 Financial Overview 164
12.9.3 Products & Services Offered 165
12.9.4 Key Developments 165
12.9.5 SWOT Analysis 165
12.9.6 Key Strategy 165
12.10 Grifols S.A. 166
12.10.1 Company Overview 166
12.10.2 Financial Overview 166
12.10.3 Products & Services Offered 167
12.10.4 Key Developments 167
12.10.5 SWOT Analysis 167
12.10.6 Key Strategy 167
12.11 Danaher Corporation 168
12.11.1 Company Overview 168
12.11.2 Financial Overview 168
12.11.3 Products & Services Offered 169
12.11.4 Key Developments 169
12.11.5 SWOT Analysis 170
12.11.6 Key Strategy 170
12.12 Sysmex Corporation 171
12.12.1 Company Overview 171
12.12.2 Financial Overview 171
12.12.3 Products & Services Offered 172
12.12.4 Key Developments 172
12.12.5 SWOT Analysis 172
12.12.6 Key Strategy 172
12.13 Thermo Fisher Scientific 173
12.13.1 Company Overview 173
12.13.2 Financial Overview 173
12.13.3 Products & Services Offered 174
12.13.4 Key Developments 174
12.13.5 SWOT Analysis 174
12.13.6 Key Strategy 175
13 Appendix
13.1 Discussion Blue Print 177
14 List of Tables
TABLE 1 MARKET SYNOPSIS 19
TABLE 2 LIST OF ASSUMPTIONS 21
TABLE 3 PERSONALIZED THERAPY AUTHORIZED IN GERMANY 31
TABLE 4 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 40
TABLE 5 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS & KITS, BY REGION 2023-2032 (USD MILLION) 41
TABLE 6 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION 2023-2032 (USD MILLION) 41
TABLE 7 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR DATA MANAGEMENT SOFTWARE, BY REGION 2023-2032 (USD MILLION) 41
TABLE 8 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR SERVICES, BY REGION 2023-2032 (USD MILLION) 42
TABLE 9 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 45
TABLE 10 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 45
TABLE 11 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 46
TABLE 12 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR IMMUNOASSAY/IMMUNOCHEMISTRY, BY REGION 2023-2032 (USD MILLION) 46
TABLE 13 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 47
TABLE 14 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION 2023-2032 (USD MILLION) 47
TABLE 15 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 47
TABLE 16 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION 2023-2032 (USD MILLION) 48
TABLE 17 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR MICROBIOLOGY, BY REGION 2023-2032 (USD MILLION) 48
TABLE 18 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION 2023-2032 (USD MILLION) 48
TABLE 19 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 50
TABLE 20 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION 2023-2032 (USD MILLION) 51
TABLE 21 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 51
TABLE 22 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR NON-INFECTIOUS DISEASES, BY REGION 2023-2032 (USD MILLION) 52
TABLE 23 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 54
TABLE 24 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION 2023-2032 (USD MILLION) 55
TABLE 25 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY REGION 2023-2032 (USD MILLION) 55
TABLE 26 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC INSTITUTES, BY REGION 2023-2032 (USD MILLION) 55
TABLE 27 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 57
TABLE 28 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 58
TABLE 29 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 59
TABLE 30 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 59
TABLE 31 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 59
TABLE 32 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 60
TABLE 33 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 60
TABLE 34 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 60
TABLE 35 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 61
TABLE 36 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 61
TABLE 37 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 61
TABLE 38 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2023-2032 (USD MILLION) 62
TABLE 39 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 62
TABLE 40 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 63
TABLE 41 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,
2023-2032 (USD MILLION) 63
TABLE 42 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 63
TABLE 43 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 64
TABLE 44 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 64
TABLE 45 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 64
TABLE 46 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 65
TABLE 47 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 65
TABLE 48 US IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 66
TABLE 49 US IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 66
TABLE 50 US IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 66
TABLE 51 US IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 67
TABLE 52 US IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 67
TABLE 53 US IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 67
TABLE 54 US IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 68
TABLE 55 US IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 68
TABLE 56 US IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 68
TABLE 57 CANADA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 69
TABLE 58 CANADA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 69
TABLE 59 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 69
TABLE 60 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 70
TABLE 61 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 70
TABLE 62 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 70
TABLE 63 CANADA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 71
TABLE 64 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 71
TABLE 65 CANADA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 71
TABLE 66 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 72
TABLE 67 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 72
TABLE 68 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,
2023-2032 (USD MILLION) 73
TABLE 69 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 73
TABLE 70 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 74
TABLE 71 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 74
TABLE 72 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 74
TABLE 73 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 75
TABLE 74 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 75
TABLE 75 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 76
TABLE 76 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 77
TABLE 77 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 77
TABLE 78 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 77
TABLE 79 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 78
TABLE 80 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 78
TABLE 81 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 78
TABLE 82 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 79
TABLE 83 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 79
TABLE 84 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 79
TABLE 85 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2023-2032 (USD MILLION) 80
TABLE 86 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 80
TABLE 87 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 81
TABLE 88 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,
2023-2032 (USD MILLION) 81
TABLE 89 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 81
TABLE 90 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 82
TABLE 91 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 82
TABLE 92 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 82
TABLE 93 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 83
TABLE 94 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 83
TABLE 95 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 84
TABLE 96 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 84
TABLE 97 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 85
TABLE 98 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 85
TABLE 99 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 86
TABLE 100 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 86
TABLE 101 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 86
TABLE 102 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 87
TABLE 103 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 87
TABLE 104 UK IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 88
TABLE 105 UK IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 88
TABLE 106 UK IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 88
TABLE 107 UK IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 89
TABLE 108 UK IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 89
TABLE 109 UK IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 89
TABLE 110 UK IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 90
TABLE 111 UK IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 90
TABLE 112 UK IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 90
TABLE 113 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 91
TABLE 114 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 91
TABLE 115 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 92
TABLE 116 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 92
TABLE 117 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 93
TABLE 118 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 93
TABLE 119 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 93
TABLE 120 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 94
TABLE 121 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 94
TABLE 122 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 95
TABLE 123 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 95
TABLE 124 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 95
TABLE 125 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 96
TABLE 126 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 96
TABLE 127 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 96
TABLE 128 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 97
TABLE 129 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 97
TABLE 130 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 97
TABLE 131 ITALY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 98
TABLE 132 ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 98
TABLE 133 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 98
TABLE 134 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 99
TABLE 135 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 99
TABLE 136 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 99
TABLE 137 ITALY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 100
TABLE 138 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 100
TABLE 139 ITALY IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 100
TABLE 140 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 101
TABLE 141 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 101
TABLE 142 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,
2023-2032 (USD MILLION) 102
TABLE 143 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 102
TABLE 144 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 103
TABLE 145 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE,
2023-2032 (USD MILLION) 103
TABLE 146 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 103
TABLE 147 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE
2023-2032 (USD MILLION) 104
TABLE 148 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 104
TABLE 149 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 105
TABLE 150 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 105
TABLE 151 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,
2023-2032 (USD MILLION) 106
TABLE 152 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 106
TABLE 153 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 107
TABLE 154 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 107
TABLE 155 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 107
TABLE 156 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 108
TABLE 157 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 108
TABLE 158 ASIA PACFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2023-2032 (USD MILLION) 109
TABLE 159 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 110
TABLE 160 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 110
TABLE 161 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 110
TABLE 162 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 111
TABLE 163 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 111
TABLE 164 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 111
TABLE 165 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 112
TABLE 166 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 112
TABLE 167 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 112
TABLE 168 CHINA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 113
TABLE 169 CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 113
TABLE 170 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 113
TABLE 171 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 114
TABLE 172 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 114
TABLE 173 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 114
TABLE 174 CHINA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 115
TABLE 175 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 115
TABLE 176 CHINA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 115
TABLE 177 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 116
TABLE 178 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 116
TABLE 179 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 116
TABLE 180 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 117
TABLE 181 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 117
TABLE 182 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 117
TABLE 183 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 118
TABLE 184 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 118
TABLE 185 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 118
TABLE 186 INDIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 119
TABLE 187 INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 119
TABLE 188 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 119
TABLE 189 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 120
TABLE 190 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 120
TABLE 191 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 120
TABLE 192 INDIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 121
TABLE 193 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 121
TABLE 194 INDIA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 121
TABLE 195 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 122
TABLE 196 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 122
TABLE 197 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 123
TABLE 198 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 123
TABLE 199 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 124
TABLE 200 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 124
TABLE 201 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 124
TABLE 202 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 125
TABLE 203 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 125
TABLE 204 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 126
TABLE 205 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 126
TABLE 206 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,
2023-2032 (USD MILLION) 127
TABLE 207 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 127
TABLE 208 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 128
TABLE 209 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 128
TABLE 210 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 128
TABLE 211 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 129
TABLE 212 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 129
TABLE 213 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY REGION 2023-2032 (USD MILLION) 130
TABLE 214 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 131
TABLE 215 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 131
TABLE 216 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,
2023-2032 (USD MILLION) 131
TABLE 217 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 132
TABLE 218 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 132
TABLE 219 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 132
TABLE 220 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 133
TABLE 221 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 133
TABLE 222 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 133
TABLE 223 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 134
TABLE 224 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 134
TABLE 225 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 135
TABLE 226 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,
2023-2032 (USD MILLION) 135
TABLE 227 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 136
TABLE 228 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 136
TABLE 229 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 136
TABLE 230 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 137
TABLE 231 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 137
TABLE 232 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2023-2032 (USD MILLION) 138
TABLE 233 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2023-2032 (USD MILLION) 138
TABLE 234 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 139
TABLE 235 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2023-2032 (USD MILLION) 139
TABLE 236 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2023-2032 (USD MILLION) 140
TABLE 237 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2023-2032 (USD MILLION) 140
TABLE 238 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2023-2032 (USD MILLION) 140
TABLE 239 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2023-2032 (USD MILLION) 141
TABLE 240 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2023-2032 (USD MILLION) 141
TABLE 241 GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY DEVELOPMENT 145
15 List of Figures
FIGURE 1 GLOBAL IN-VITRO DIAGNOSTICS MARKET: MARKET STRUCTURE 22
FIGURE 2 RESEARCH PROCESS OF MRFR 24
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 27
FIGURE 4 VALUE CHAIN 38
FIGURE 5 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2020 & 2027 (USD MILLION) 40
FIGURE 6 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2020 & 2027 (USD MILLION) 44
FIGURE 7 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 50
FIGURE 8 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER 2020 & 2027 (USD MILLION) 54
FIGURE 9 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION 2020 & 2027 (USD MILLION) 57
FIGURE 10 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY REGION COUNTRY 2020 (%) 58
FIGURE 11 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 62
FIGURE 12 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY REGION 2020 (%) 76
FIGURE 13 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 80
FIGURE 14 ASIA PACFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 & 2027 (USD MILLION) 109
FIGURE 15 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 130
FIGURE 16 GLOBAL IN-VITRO DIAGNOSTICS MARKET, COMPETITIVE LANDSCAPE (%) 143
FIGURE 17 GLOBAL IN-VITRO DIAGNOSTICS MARKET, MARKET SHARE ANALYSIS 2020 (%) 144
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
